Summary & Overview
HCPCS J1105: Dexmedetomidine, Oral, 1 mcg
HCPCS Level II code J1105 denotes oral dexmedetomidine, 1 mcg. The code identifies billing for the oral formulation of dexmedetomidine, a sedative-analgesic used in clinical settings where oral administration is appropriate. Nationally, accurate reporting of J1105 matters for clinical documentation, payer adjudication, and tracking utilization of sedative agents outside of injectable formulations.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, typical sites of service where the oral formulation is administered, and contextual clinical considerations relevant to coding and billing. The publication summarizes benchmarks where available, highlights recent policy updates affecting HCPCS billing for oral therapeutic agents, and explains practical coding details for revenue cycle professionals.
The report is intended for clinicians, billing professionals, and policy analysts seeking a concise reference on HCPCS Level II code J1105, including service definitions, payer scope, and the regulatory context that affects reimbursement and compliance. Data not available in the input is identified as such rather than inferred.
Billing Code Overview
HCPCS Level II code J1105 represents dexmedetomidine, oral, 1 mcg. This code is used to report the oral formulation of dexmedetomidine, a sedative-analgesic agent commonly employed for its sedative and anxiolytic properties.
Service type: Oral medication administration
Typical site of service: Outpatient clinics, ambulatory care settings, and other sites where oral medication is administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old male with severe agitation and delirium in the intensive care unit following major abdominal surgery who requires light sedation without respiratory depression. The intensivist orders oral dexmedetomidine to provide anxiolysis and cooperative sedation while facilitating wakefulness for neurological assessments and minimizing opioid requirements. Nursing prepares and documents administration of J1105 as a measured oral microdose (1 mcg unit) per facility protocol. Vital signs, sedation scores (e.g., RASS), and hemodynamics are monitored before and after dosing. If the patient subsequently requires deeper sedation for procedures or mechanical ventilation, escalation to IV sedatives and appropriate airway management is coordinated with anesthesia and respiratory therapy. Billing staff attach appropriate modifiers to J1105 based on circumstance (e.g., JW for wasted drug if partial unit discarded) and submit the claim to the patient’s payer with the corresponding diagnosis codes for delirium, agitation, or post-operative pain management as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered to the patient |